Despite advances in targeted therapies, FLT3-mutated acute myeloid leukemia (AML) remains associated with poor outcomes, driven in part by challenges in timely and accurate diagnosis, risk stratification, and treatment selection. Variability in molecular testing practices, under recognition of FLT3 mutation subtypes, and inconsistent application of evolving guidelines contribute to missed opportunities for optimal care. Clinicians must also navigate an expanding body of clinical trial data and real-world evidence, creating uncertainty in integrating newer therapies and managing adverse events effectively. This activity utilizes instructional cases referred to or managed by the consulting faculty to illustrate common diagnostic and therapeutic pitfalls in FLT3-mutated AML. Expert-led discussions will highlight current evidence, reinforce best practices in molecular testing and treatment selection therapeutic and translate published research into practical management strategies for supports clinical decision-making.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedMay 8, 2026
-
Last day to claim creditMay 26, 2027 8 months left
-
Medscape, LLC Autumn Updates: Exploring Innovations in EGFR-Mutated NSCLC
-
PRIME Education, Inc. (PRIME®) Clinical Momentum: Advancements for Menin Inhibitors in NPM1-Mutated AML
-
Clinical Care Options, LLC (dba Decera Clinical Education) Management of a Patient With EGFR-Mutated NSCLC and Brain Metastases
-
Efficient CME, CME Outfitters, LLC From Gaps to Gains: A Microlearning Exploration of Persistent Challenges and Emerging Solutions in the Treatment of Adolescents and Adults with B-Cell Precursor Acute Lymphoblastic Leukemia
-
Efficient CME, CME Outfitters, LLC Evidence in Action: Using Expert Insights and Practice Patterns to Guide Optimal Treatment of Chronic Lymphocytic Leukemia
-
Efficient CME, CME Outfitters, LLC Bridging Evidence and Experience: Using Expert Insights and Practice Patterns to Guide Optimal Treatment of Myelofibrosis
